The Cigna Group (CI)

NYSE: CI · USD

$275

+4.76 (+1.8%)· Recorded snapshot

Coverage state: Latest published research available

Market snapshot recorded 2026-08-07 02:00 UTC. Latest published research analyzed 2026-05-12 · stale · sources unverified. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate a fresh CI analysis

The published report stays available while a new owner-requested analysis runs.

StockMarketAgent Research · Analyzed 2026-05-12

Our latest published analysis: CI rated Strong Buy

CI is rated Strong Buy at $289.07 versus the reconciled fair value midpoint of $561.36, implying +94.20% upside/downside. Confidence is separately disclosed at 83/100.

Fair value (mid)

$561 / share

$382 – $743

Upside to FV

+94.2%

from $275

Confidence

83/100

Moat

9/10

Read full analysis

Market cap	$76.5B
Revenue (ttm)	282.4B
Net income (ttm)	6.4B
EPS (ttm)	$24.2
Shares out	264.2M
P/E (trailing)	11.4x
P/E (forward)	8.6x
Dividend	$6.24 (2.27%)
Volume	2,978,328
Beta	0.32
Price target	$341	+24.0%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 282.4B
Net income (ttm): 6.4B
EPS (ttm): $24.2
P/E (trailing): 11.4x
P/E (forward): 8.6x
Market cap: $76.5B

Item	P1	P2	P3	P4	P5	Trend
Period	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31	Trend
Revenue	$174.27B	$180.03B	$195.19B	$244.38B	—	+8.8%
Gross profit	—	—	—	—	—	—
Operating income	—	—	—	—	—	—
Net income	$5.37B	$6.70B	$5.16B	$3.43B	—	-10.6%
EPS (diluted)	—	$21.30	$17.39	$12.12	$22.18	+1.0%
EBITDA	—	—	—	—	—	—
R&D	—	—	—	—	—	—
SG&A	$13.01B	$13.17B	$14.82B	$14.84B	—	+3.3%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AAPL	Apple Inc.	4.6T	35.8x	9.8x	101.6%	+6.1%	+54.6%	Sell
ABNB	Airbnb Inc.	90B	37.2x	6.8x	16.8%	+24.4%	+16.7%	Hold
ADBE	Adobe Inc.	103.4B	14.9x	4.1x	60.7%	+11.9%	-23.2%	Strong Buy
ABBV	AbbVie Inc.	430.9B	69.6x	6.7x	17.7%	+3.7%	+26.6%	Hold
ABT	Abbott Laboratories	186.8B	34.9x	4.0x	7.5%	+3.0%	-15.5%	Strong Buy
AMGN	Amgen Inc.	218.9B	25.2x	5.7x	19.8%	+8.4%	+39.0%	Strong Buy

All CI indicators

Market & fundamental data

Available fields

284

Groups with data

Currency

USD

Showing 284 of 284 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001739940
Company name	The Cigna Group
Country	United States
Country code	US
Cusip	125523100
Employees	67,700
Employees Change	-5,800%
Employees Change Percent	-7.89
Enterprise value	$97.4B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
In Index	SP500
Industry	Healthcare Plans
Industry PE	28.61
Industry PE Fwd	15.73
Isin	US1255231003
Last refreshed	2026-08-07
Market cap	$72.7B
Market cap category	Large-Cap
Price	$275
Price currency	USD
Rev Per Employee	4,171,078.29x
Sector	Healthcare
Sector PE	48.77
Sector PE Fwd	22.51
Sic	6324
Symbol	CI
Website	https://www.thecignagroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	8.82%
EV Earnings	15.17x
EV Sales Forward	0.33x
EV/EBIT	9.78x
EV/EBITDA	7.68x
EV/FCF	10.68x
EV/Sales	0.34x
FCF yield	12.53%
Forward P/E	8.68x
P/B ratio	1.7x
P/E ratio	11.38x
P/S ratio	0.26x
PE Ratio10 Y	16.32x
PE Ratio3 Y	18.63x
PE Ratio5 Y	16.34x
PEG ratio	0.81x
PS Forward	0.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.53%
EBITDA Margin	4.49%
FCF margin	3.23%
Gross margin	9.14%
Gross Profit	$25.8B
Gross Profit Growth	-0.13%
Gross Profit Growth Q	6.07%
Gross Profit Growth3 Y	3.06%
Gross Profit Growth5 Y	2.25%
Net Income	$6.4B
Net Income Growth	27.86%
Net Income Growth Q	8.36%
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Net Income Growth3 Y	-1.32%
Net Income Growth5 Y	-4.67%
Pretax Margin	3.06%
Profit Margin	2.27%
Profit Per Employee	$94,771
Profitable Quarters	$9
Profitable Years	23
ROA	4.46
Roa5y	3.74
ROCE	9.81
ROE	16.76
Roe5y	12.28
ROIC	13.39
Roic5y	10.87

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	9.01%
Cagr15y	13.58%
Cagr1y	3.92%
Cagr20y	11.48%
Cagr3y	0.56%
Cagr5y	7.92%
Div CAGR10	65.56%
Div CAGR3	8.77%
Div CAGR5	15.59%
EPS Growth	32.61
EPS Growth Q	10.16
EPS Growth Quarters	2
EPS Growth Years	1
EPS Growth3 Y	3.06
EPS Growth5 Y	1.12
FCF Growth	131.06%
FCF Growth3 Y	-7.23%
FCF Growth5 Y	13.14%
OCF Growth	94.2%
OCF Growth10 Y	13.04%
OCF Growth3 Y	-7.3%
OCF Growth5 Y	11.42%
Revenue Growth	7.77x
Revenue Growth Q	6.68x
Revenue Growth Quarters	66x
Revenue Growth Years	16x
Revenue Growth3 Y	14.9x
Revenue Growth5 Y	11.11x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.83
Assets	$157.1B
Cash	$7.3B
Current Assets	$47B
Current Liabilities	$55.6B
Debt	$31.9B
Debt EBITDA	$2.51
Debt Equity	$0.74
Debt FCF	$3.5
Equity	$42.9B
Interest Coverage	7.03
Liabilities	$114.2B
Long Term Assets	$110.1B
Long Term Liabilities	$58.6B
Net Cash	$-24.6B
Net Cash By Market Cap	$-33.85
Net Debt EBITDA	$1.94
Net Debt Equity	$0.57
Net Debt FCF	$2.7
Tangible Book Value	$-29.8B
Tangible Book Value Per Share	$-113
WACC	5.27

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.85
Inventory Turnover	43.44
Net Working Capital	$-13B
Quick ratio	0.69
Working Capital	$-8.6B
Working Capital Turnover	$-27.38

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	3.55%
Dividend Growth	4.38%
Dividend Growth Years	5%
Dividend per share	$6.24
Dividend Years	45
Dividend Yield	2.27%
Ex Div Date	2026-09-08
Last Dividend	$1.56
Payout Frequency	Quarterly
Payout Ratio	25.8%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	137.02%
1Y total return	3.92%
200-day SMA	279.5
3Y total return	1.69%
50-day SMA	285.9
50-day SMA vs 200-day SMA	50over200
5Y total return	46.35%
All Time High	370.8
All Time High Change	-25.77%
All Time High Date	2024-09-16
All Time Low	3
All Time Low Change	9,075%
All Time Low Date	1984-07-19
ATR	8.86
Beta	0.32
Beta1y	0.14
Beta2y	0.26
Ch YTD	0.01
High	276.7
High52	315.5
High52 Date	2025-10-03
High52ch	-12.75%
Low	269
Low52	239.5
Low52 Date	2025-11-03
Low52ch	14.92%
Ma50ch	-3.72%
Premarket Change Percent	1.13
Premarket Price	$274
Premarket Volume	10,910
Price vs 200-day SMA	-1.52%
RSI	42.56
RSI Monthly	46.84
RSI Weekly	46.53
Sharpe ratio	0.16x
Sortino ratio	0.37
Total Return	5.81%
Tr YTD	1.14
Tr15y	575.81%
Tr1m	-4.35%
Tr1w	-4.31%
Tr3m	0.43%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	24
Analyst Count Top	12
Analyst Price Target Top	$346
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$7.57
Earnings EPS Estimate Growth	5.14
Earnings Revenue Estimate	70,378,514,728x
Earnings Revenue Estimate Growth	4.83x
Operating Income	$11B
Operating Income Growth	12.72
Operating Income Growth Q	15.72
Operating Income Growth3 Y	10.7
Operating Income Growth5 Y	7.44
Operating margin	3.9
Price target	$341
Price Target Change	$24.04
Price Target Change Top	$25.87

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	262,911,650%
Float Percent	99.5%
Net Borrowing	1,062,000,000
Shares Insiders	0.38%
Shares Institutions	92.49%
Shares Out	264,240,486
Shares Qo Q	-0.02%
Shares Yo Y	-3.55%
Short Float	2.35%
Short Ratio	3.93
Short Shares	2.34

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	1,952,154.75x
Bv Per Share	161.6
CAPEX	$-1.2B
Ch10y	114.2
Ch15y	509.1
Ch1m	-4.35
Ch1w	-4.31
Ch1y	1.67
Ch20y	686.1
Ch3m	-0.15
Ch3y	-3.95
Ch5y	33.48
Ch6m	-3.26
Change	1.76%
Change From Open	0.69
Close	270.5
Days Gap	1.06
Depreciation Amortization	1,737,000,000
Dollar Volume	819,784,782
Earnings Date	2026-07-30
Earnings Time	bmo
EBIT	$10B
EBITDA	$12.7B
EPS	$24.18
F Score	6
FCF	$9.1B
FCF EV Yield	9.36x
FCF Per Share	$34.49
Financing CF	-2,341,000,000
Fiscal Year End	December
Founded	1,792
Goodwill	45,534,000,000
Graham Number	296.55341
Graham Upside	7.74
Income Tax	$1.7B
Investing CF	-5,947,000,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-07-30
Last Report Date	2026-06-30
Last Split Date	2007-06-05
Last Split Type	Forward
Last10k Filing Date	2026-02-26
Lynch Fair Value	$121
Lynch Upside	-56.07
Ma150	280.9
Ma150ch	-2.02%
Ma20	287.8
Ma20ch	-4.37%
Net CF	1,970,000,000
Next Earnings Date	2026-10-29
Open	273.4
Optionable	Yes
P FCF Ratio	7.98
P OCF Ratio	7.08
Payment Date	2026-09-23
Position In Range	80.83
Post Close	275.3
Postmarket Change Percent	-0.89
Postmarket Price	$273
Ppne	3,736,000,000
Pre Close	270.5
Price Date	2026-08-06
Price EBITDA	$5.74
Relative Volume	1.53x
Revenue	282,382,000,000x
Tax By Revenue	0.59x
Tax Rate	19.17%
Tr20y	778.47%
Tr6m	-2.16%
Us State	Connecticut
Volume	2,978,328
Z Score	2.81

Frequently asked questions

About this CI report

What is the latest published CI stock rating?

The Cigna Group is shown with strong buy in the latest published report, analyzed 2026-05-12. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CI analysis?

The full latest published report, analyzed 2026-05-12, lives at /stocks/CI/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair-value range is used for CI?

The latest published report analyzed 2026-05-12 frames CI around USD 382 to USD 743. This is a dated valuation range, not a live market price; check the valuation, sensitivity, and bear-case tabs before making a decision.

How often is the CI page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-05-12). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

The Cigna Group (CI)

Coverage state: Latest published research available

Generate a fresh CI analysis

Our latest published analysis: CI rated Strong Buy

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · CI

Valuation

Profitability

Balance sheet

Trading

Position sizing & entry playbook

Next earnings

Sector percentile context

All CI indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on CI

Frequently asked questions